Calreticulin (CRT) is a multifunctional chaperone protein primarily located in the endoplasmic reticulum (ER). It plays essential roles in calcium homeostasis, protein folding, and cellular stress responses[@supa2000]. Calreticulin is increasingly recognized for its involvement in neurodegenerative diseases.
Calreticulin (CRT) is a multifunctional chaperone protein primarily located in the endoplasmic reticulum (ER). It plays essential roles in calcium homeostasis, protein folding, and cellular stress responses[@supa2000]. Calreticulin is increasingly recognized for its involvement in neurodegenerative diseases.
Structure
Calreticulin contains several key domains:
N-terminal domain: Chaperone activity and ER retention signal (KDEL)
Central domain: P-domain - calcium binding with high capacity
C-terminal domain: C-domain - calcium binding with low capacity
Cardiac function: Critical for cardiac muscle contractility
Role in Disease
Alzheimer's Disease
ER stress activates calreticulin expression
Surface calreticulin on [neurons](/entities/neurons) may promote microglial phagocytosis
A\u03b2 induces calreticulin translocation to the nucleus
Potential biomarker for neuronal stress
Parkinson's Disease
Calreticulin is upregulated in PD brains
ER stress in dopaminergic neurons involves calreticulin
May contribute to neuroinflammation
ALS
Mutant SOD1 induces calreticulin expression
Calreticulin modulates inflammatory responses
Dysregulated calcium homeostasis contributes to motor neuron vulnerability
Cancer
Calreticulin surface expression is a key prognostic marker
Immunogenic cell death triggers anti-tumor immune responses
Therapeutic Targeting
Research Directions
Current research explores:
Calreticulin as a biomarker for neurodegenerative diseases
Modulating calreticulin for therapeutic benefit
Understanding the role of nuclear calreticulin in gene regulation
Introduction
Calreticulin is a multifunctional chaperone protein located primarily in the endoplasmic reticulum (ER) lumen. It plays crucial roles in calcium homeostasis, protein folding, and cellular stress responses. Recently, calreticulin has been implicated in neurodegeneration through its involvement in ER stress, calcium dysregulation, and immune modulation.
Therapeutic Implications
Calreticulin modulation: Therapeutic target in cancer and neurodegeneration
Immunotherapy: CALR mutations as neoantigens in myeloproliferative neoplasms
ER stress modulation: [UPR](/entities/unfolded-protein-response)-targeted therapies
Immunogenic cell death: Calreticulin exposure in cancer therapy
Neuroprotection: Enhancing ER function in neurodegeneration
Gene therapy: Viral vector delivery of CALR
Background
The study of Calreticulin Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.